Mobile TeleSystems OJSC – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

• Publication date: May 2012
• Report size: 110 pages

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: Datamonitors' Impax Laboratories, Inc. (formerly Global Pharmaceutical Corporation) Mergers & Acquisitions (M&A), Partnerships &...

Project Synopsis:

Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Project Description:

Datamonitors' Impax Laboratories, Inc. (formerly Global Pharmaceutical Corporation) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Impax Laboratories, Inc. (formerly Global Pharmaceutical Corporation) since January 2007.

Scope:

– Provides intelligence on Impax Laboratories, Inc. (formerly Global Pharmaceutical Corporation)'s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
– Detailed reports of various financial transactions undertaken by Impax Laboratories, Inc. (formerly Global Pharmaceutical Corporation) and its subsidiaries since 2007.
– Information about key financial and legal advisors for Impax Laboratories, Inc. (formerly Global Pharmaceutical Corporation)'s financial deals transactions.
– Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Highlights:

This report includes Impax Laboratories, Inc. (formerly Global Pharmaceutical Corporation)'s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Impax Laboratories, Inc. (formerly Global Pharmaceutical Corporation). These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Reasons to Purchase:

– Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
– Form an independent opinion about Impax Laboratories, Inc. (formerly Global Pharmaceutical Corporation)’s growth strategies through the organic and inorganic activities undertaken since 2007.
– Track your competitors’ business structure and growth strategies.
Disclaimer: Deals will be included in the reports for only those years in which the company has engaged in such transactions and not necessarily for all the years.

Global Pharmaceutical Industry

TABLE OF CONTENTS

COMPANY OVERVIEW AND KEY FACTS
PARTNERSHIP
--Partnership – Overview
--Partnership – Deal reports

APPENDIX
--About Datamonitor Financial Deals Database
--Deal Definition and Methodology
--About Datamonitor
--Datamonitor Professional Services Knowledge Center

LIST OF TABLES

--Impax Laboratories activity by deal type – volume (2011-TTM2012)
--Impax Laboratories activity by deal type – volume (2008 -YTD2012)
--Impax Laboratories legal advisor ranking by value ($m)
--Top Deals(2008 -YTD2012)
--Impax Laboratories targets and partners (2008 -YTD2012)
--Impax Laboratories partnership volume and value trend (2008-YTD2012)
--Impax Laboratories partnership trend by key deal type (2008-YTD2012)

LIST OF FIGURES

--Impax Laboratories activity by deal type - volume (trailing twelve months (TTM))
--Impax Laboratories activity by deal type - volume (2008-YTD2012)
--Impax Laboratories partnership volume and value trend (2008-YTD2012)
--Impax Laboratories partnership trend by key deal type (2008-YTD2012)

Pharmaceutical in World

Cuba Poisonings, 45-59 Yrs, Male, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pharmaceutical
• Countries : Cuba, World

Fiji Poisonings, 70+ Yrs, Male, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pharmaceutical
• Countries : Fiji, World

Cook Islands Poisonings, 45-59 Yrs, Male, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pharmaceutical
• Countries : World

Iran Poisonings, 30-44 Yrs, Male, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pharmaceutical
• Countries : Iran, World

Saint Vincent Poisonings, 15-29 Yrs, Male, Dalys

• $ 250
• Industry data
• May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

• Industries : Pharmaceutical
• Countries : World